I recently covered Carlsmed’s bold $100M IPO bid, noting how rare orthopedic offerings have been in recent years.
Now, Shoulder Innovations is stepping up to the plate with its own $100M filing. Whether SI, Carlsmed, or even Hinge Health emerge as breakout successes or cautionary tales remains to be seen—but it’s notable that these companies are testing the public markets in a sector where only Monogram (2023) and Treace (2021) have dared to go public in the last several years.
Shoulder Innovations, Inc. (SI), a medical device company specializing in shoulder arthroplasty, has initiated efforts to go public through a U.S. initial public offering (IPO). The Grand Rapids, Michigan-based firm filed with the SEC to raise $100 million, aiming to accelerate its commercialization plans, research and development (R&D), and operational growth. This move comes amid a growing market for shoulder replacement technologies, driven by an aging population and advancements in surgical procedures.
Company Overview
Founded to enhance shoulder surgical care, Shoulder Innovations focuses on improving preoperative planning, implant design, and procedural efficiency. The company develops innovativ...
